Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
09 2019
Historique:
received: 05 10 2018
accepted: 07 02 2019
pubmed: 9 2 2019
medline: 29 7 2020
entrez: 9 2 2019
Statut: ppublish

Résumé

Burkitt-like lymphoma with 11q aberration is characterized by pathological features and gene expression profile resembling those of Burkitt lymphoma but lacks the

Identifiants

pubmed: 30733272
pii: haematol.2018.207928
doi: 10.3324/haematol.2018.207928
pmc: PMC6717587
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1822-1829

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

Mol Cell Biol. 2000 Mar;20(5):1797-815
pubmed: 10669755
Blood. 2000 Mar 15;95(6):2104-10
pubmed: 10706881
Br J Haematol. 2006 Jul;134(1):27-36
pubmed: 16803564
Leukemia. 2009 Feb;23(2):323-31
pubmed: 19020548
Br J Haematol. 2010 Jan;148(2):245-55
pubmed: 19832807
J Acquir Immune Defic Syndr. 2010 May 1;54(1):18-26
pubmed: 20216076
Br J Haematol. 2010 May;149(4):569-77
pubmed: 20230398
Haematologica. 2010 Dec;95(12):2047-55
pubmed: 20823134
Blood. 2011 Jul 7;118(1):139-47
pubmed: 21487109
J Clin Oncol. 2012 Oct 1;30(28):3452-9
pubmed: 22851565
Nature. 2012 Oct 4;490(7418):116-20
pubmed: 22885699
Nat Genet. 2012 Dec;44(12):1316-20
pubmed: 23143595
Nat Genet. 2012 Dec;44(12):1321-5
pubmed: 23143597
Blood. 2013 Aug 15;122(7):1256-65
pubmed: 23699601
Blood. 2013 Sep 26;122(13):2233-41
pubmed: 23926301
Blood. 2014 Mar 13;123(11):1681-90
pubmed: 24037725
Blood. 2014 Feb 20;123(8):1187-98
pubmed: 24398325
Blood. 2014 Feb 20;123(8):1214-7
pubmed: 24398326
Leukemia. 2015 Aug;29(8):1789-91
pubmed: 25673238
Haematologica. 2015 Jul;100(7):e275-9
pubmed: 25795716
Cancer Genet. 2016 Mar;209(3):117-8
pubmed: 26776268
Blood. 2016 Aug 25;128(8):1101-11
pubmed: 27257180
Am J Surg Pathol. 2017 Jul;41(7):877-886
pubmed: 28288039
Leukemia. 2018 Mar;32(3):675-684
pubmed: 28804123
Am J Clin Pathol. 2017 Dec 20;149(1):17-28
pubmed: 29272887
Mod Pathol. 2018 May;31(5):732-743
pubmed: 29327714
Blood. 2018 Jul 26;132(4):369-375
pubmed: 29895666
Haematologica. 2019 Apr;104(4):e154-e157
pubmed: 30309852
Haematologica. 2019 Jun;104(6):e248-e251
pubmed: 30523057
Blood. 2019 Feb 28;133(9):962-966
pubmed: 30567752

Auteurs

Blanca Gonzalez-Farre (B)

Hematopathology Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Joan Enric Ramis-Zaldivar (JE)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Julia Salmeron-Villalobos (J)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Olga Balagué (O)

Hematopathology Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Verónica Celis (V)

Pediatric Oncology Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.

Jaime Verdu-Amoros (J)

Pediatric Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.

Ferran Nadeu (F)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Constantino Sábado (C)

Pediatric Oncology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Antonio Ferrández (A)

Pathology Department, Hospital Clínico de Valencia, Valencia, Spain.

Marta Garrido (M)

Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Federico García-Bragado (F)

Pathology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.

María Dolores de la Maya (MD)

Pediatric Hematology Department, Hospital Materno Infantil de Badajoz, Badajoz, Spain.

José Manuel Vagace (JM)

Pediatric Hematology Department, Hospital Materno Infantil de Badajoz, Badajoz, Spain.

Carlos Manuel Panizo (CM)

Department of Hematology, Clínica Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.

Itziar Astigarraga (I)

Pediatrics Department, Hospital Universitario Cruces, IIS Biocruces Bizkaia, UPV/EHU, Barakaldo, Spain.

Mara Andrés (M)

Pediatric Oncology Department, Hospital La Fe, Valencia, Spain.

Elaine S Jaffe (ES)

Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Elias Campo (E)

Hematopathology Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Itziar Salaverria (I)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain isalaver@clinic.cat.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH